Navidea Biopharmaceuticals Inc (NAVB): All in all, the conference call went wel...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	35
Posts	1086
Boards Moderated	0
Alias Born	11/26/2010

XJINVESTOR

Re: None

Thursday, 09/22/2016 1:06:22 PM

Thursday, September 22, 2016 1:06:22 PM

All in all, the conference call went well. There was no earth shattering news, but it is available for everyone to listen. If you did not get a chance to listen to it and you own or are thinking of owning it, then you need to listen as responsible DD.

From what I gather, the deal with Cardinal is a done deal. This will pay off the loan to CRG and they will emerge debt free. This is huge for this company - we absolutely had to have it.

They have a very good pipeline as well as product they are very excited about and it looks like it works extremely well. It's cutting edge technology. They want to develop it in the worst way and I think they just need to get out from under this loan to get on with it.

It's all good, really. This should continue to grind upward - but this is not a 1.00 stock. It's worth at least 1.50 and if this continues to work and get developed, much much more!